Skip to main contentSkip to navigation
Sirius Investors
CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group Limited

CHJTF
OTCHealthcare

CSPC Pharmaceutical Group Limited (CHJTF) Investment Research Dashboard

About CSPC Pharmaceutical Group Limited (CHJTF) stock analysis

Get live CHJTF stock price $1.07, comprehensive CSPC Pharmaceutical Group Limited stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time CHJTF stock data and investment insights.

1.07
0.00%Today
Market Cap
12.20B
Volume
5.00K
52W High
1.39
52W Low
0.94

Loading chart data...

CSPC Pharmaceutical Group Limited (CHJTF) Overview

CSPC Pharmaceutical Group Limited (CHJTF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, CHJTF trades at $1.07 with a market capitalization of 12.20B . Over the past 52 weeks, CHJTF has traded between $0.94 and $1.39 , with the current price positioned at approximately 29% of this range . ...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - General)
  • Market cap: 12.20B
  • Current price: $1.07
  • 52-week range: $0.94 - $1.39
  • P/E ratio: 22.06

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

CSPC Pharmaceutical Group Limited operates as an investment holding company with a core focus on the research, development, manufacturing, and global commercialization of pharmaceutical products. Its extensive operations span the People's Republic of...

Company Information

CEO
Lei Cai
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
19700

Contact Information

Address
No. 226 Huanghe Street
Country
CN

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - General

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 22.1)

Lower volatility stock (Beta: 0.72) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for CSPC Pharmaceutical Group Limited shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for CSPC Pharmaceutical Group Limited
  • Investors should consider how CSPC Pharmaceutical Group Limited fits within their overall portfolio allocation

Market Cap

12.20B

P/E Ratio (TTM)

22.06

Beta

0.72

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

80/100 ⭐⭐⭐⭐⭐

Overall
+0.7%
NYSE
+0.6%
NASDAQ
+0.7%
Sector1D1W1MP/EScore
Financial Services+2.2%+5.7%+6.1%19.3
98/100⭐⭐⭐⭐⭐
Communication Services+1.4%+2.9%+4.3%22.2
86/100⭐⭐⭐⭐⭐
Healthcare+0.7%+3.3%+3.5%24.1
80/100⭐⭐⭐⭐⭐
Basic Materials+0.4%+1.1%-0.2%25.2
56/100⭐⭐⭐⭐
Consumer Defensive-0.2%+1.7%+1.2%29.7
56/100⭐⭐⭐⭐
Real Estate-0.5%-0.1%-1.6%29.2
43/100⭐⭐⭐
Energy-2.1%-5.8%-5.1%19.1
39/100⭐⭐
Utilities-1.0%-3.0%-5.9%26.8
28/100⭐⭐
Industrials+0.6%+1.7%-11.2%30.1
26/100⭐⭐
Consumer Cyclical+0.5%-0.4%-6.3%43.0
21/100
Technology+0.6%-2.3%-9.6%40.7
17/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.